Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending March 12 2023

Healthcare Private Placement and M&A Transactions Review Week Ending March 12 2023

by Jonathan Hodson-Walker | Mar 15, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Bicara Therapeutics: The company raised $108 million of Series B venture funding in a deal led by Red Tree Venture Capital and RA Capital Management on March 6, 2023, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending March 5 2023

Healthcare Private Placement and M&A Transactions Review Week Ending March 5 2023

by Jonathan Hodson-Walker | Mar 8, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Cargo Therapeutics: The company raised $200 million of Series A1 venture funding in a deal led by Third Rock Ventures, Xontogeny, and RTW Investments on March 1, 2023, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending February 26 2023

Healthcare Private Placement and M&A Transactions Review Week Ending February 26 2023

by Jonathan Hodson-Walker | Mar 1, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Capsida Biotherapeutics: The company raised $70 million of venture funding from AbbVie on February 23, 2023. The company is a developer of targeted gene therapies intended to treat debilitating...
Healthcare Private Placement and M&A Transactions Review Week Ending February 19 2023

Healthcare Private Placement and M&A Transactions Review Week Ending February 19 2023

by Jonathan Hodson-Walker | Feb 22, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Hexagon Bio: The company raised $77.3 million of Series B venture funding from 8VC, Two Sigma Ventures and The Column Group on February 13, 2023. Nextech Invest, bpd partners and CPP...
Healthcare Private Placement and M&A Transactions Review Week Ending February 12 2023

Healthcare Private Placement and M&A Transactions Review Week Ending February 12 2023

by Jonathan Hodson-Walker | Feb 16, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Alleviant Medical: The company raised $75 million of Series 1 venture funding in a deal led by S3 Ventures and RiverVest Venture Partners on February 7, 2023, putting the company’s...
Healthcare Private Placement and M&A Transactions Review Week Ending February 5 2023

Healthcare Private Placement and M&A Transactions Review Week Ending February 5 2023

by Jonathan Hodson-Walker | Feb 8, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Alto Neuroscience: The company raised $60 million of Series B venture funding in a deal led by Lightswitch Learning and Alkeon Capital Management on January 30, 2023, putting the...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives